Korro Bio’s $116 Million Series B Financing

Martina Bellini North America Legal Chronicle
Tagged:

Goodwin advised Korro Bio on the deal.Korro Bio, Inc. announced its $116 million Series B financing. Korro is an RNA editing company focused on discovery and…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here